Patients, carers and members of the public bring valuable views and the lived experience to research. This ensures new or better treatments meet the needs of patients. We aim to involve patients and the public in research as active partners and in all stages in the development of novel treatment approaches at the UCL Blood and Transplant Research Unit (UCL BTRU) in Stem Cells and Immunotherapies.
First virtual Lay Panel meeting on 1 May 2020
The dedicated UCL BTRU Lay Panel and other patient advisory groups provide valuable insights on the research at the unit. Our Lay Panel consists of nine members adding a wealth of skills and experiences to stem cell and immunotherapy research to better treat cancer of the blood and lymph nodes as well as inherited genetic disorders.
Working with the UCL BTRU Lay Panel on ways to integrate Patient and Public Involvement in the proposed research was very rewarding and led to some novel ideas to add real value to our programme. – Professor Karl Peggs, Director of the UCL BTRU
Visit our news and events page about upcoming opportunities to meet UCL BTRU team members and updates on our work.
If you have any questions about Patient and Public Involvement and Engagement (PPIE), please contact Linda von Neree (PPIE Coordinator) at email@example.com or 020 3108 7641